{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:02:41Z","timestamp":1793109761344,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-022-00750-x","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T08:08:46Z","timestamp":1668845326000},"page":"230-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-glomerular basement membrane glomerulonephritis concurrent with membranous nephropathy and acute tubular interstitial nephritis in a lung cancer patient treated with pembrolizumab"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-7030","authenticated-orcid":false,"given":"Azusa","family":"Hoshina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"750_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","volume":"90","author":"FB Cortazar","year":"2016","unstructured":"Cortazar FB, Marrone KA, Troxell ML, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016;90:638\u201347.","journal-title":"Kidney Int"},{"key":"750_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.kint.2019.07.022","volume":"97","author":"MA Perazella","year":"2020","unstructured":"Perazella MA, Shirali AC. Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do? Kidney Int. 2020;97:62\u201374.","journal-title":"Kidney Int"},{"key":"750_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ekir.2020.10.002","volume":"6","author":"A Kitchlu","year":"2021","unstructured":"Kitchlu A, Jhaveri KD, Wadhwani S, et al. A systematic review of immune checkpoint inhibitor-associated glomerular disease. Kidney Int Rep. 2021;6:66\u201377.","journal-title":"Kidney Int Rep"},{"key":"750_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/ndtplus\/sfp177","volume":"3","author":"C Sammartino","year":"2010","unstructured":"Sammartino C, Goodman D, Flanagan G, Hill P. Anti-GBM disease following CTLA4 blockade in a patient with metastatic melanoma. Clin Kidney J. 2010;3:135\u20137.","journal-title":"Clin Kidney J"},{"key":"750_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.lungcan.2018.05.015","volume":"122","author":"N Takahashi","year":"2018","unstructured":"Takahashi N, Tsuji K, Tamiya H, et al. Goodpasture\u2019s disease in a patient with advanced lung cancer treated with nivolumab: an autopsy case report. Lung Cancer. 2018;122:22\u20134.","journal-title":"Lung Cancer"},{"key":"750_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13256-021-02766-w","volume":"15","author":"P Kyriazis","year":"2021","unstructured":"Kyriazis P, Tiwary A, Freeman J, et al. Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report. J Med Case Rep. 2021;15:186.","journal-title":"J Med Case Rep"},{"key":"750_CR7","doi-asserted-by":"publisher","first-page":"619147","DOI":"10.3389\/fimmu.2021.619147","volume":"12","author":"M Chen","year":"2021","unstructured":"Chen M, Zhang L, Zhong W, et al. Case report: THSD7A-positive membranous nephropathy caused by Tislelizumab in a lung cancer patient. Front Immunol. 2021;12:619147.","journal-title":"Front Immunol"},{"key":"750_CR8","doi-asserted-by":"publisher","first-page":"e001287","DOI":"10.1136\/jitc-2020-001287","volume":"8","author":"JS Lin","year":"2020","unstructured":"Lin JS, Wang DY, Mamlouk O, et al. Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab. J Immunother Cancer. 2020;8:e001287. https:\/\/doi.org\/10.1136\/jitc-2020-001287.","journal-title":"J Immunother Cancer"},{"key":"750_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","volume":"89","author":"SH Nasr","year":"2016","unstructured":"Nasr SH, Collins AB, Alexander MP, et al. The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int. 2016;89:897\u2013908.","journal-title":"Kidney Int"},{"key":"750_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2172-14-19","volume":"14","author":"Z Qu","year":"2013","unstructured":"Qu Z, Cui Z, Liu G, Zhao MH. The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease. BMC Immunol. 2013;14:19.","journal-title":"BMC Immunol"},{"key":"750_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.humimm.2009.04.004","volume":"70","author":"J Zhao","year":"2009","unstructured":"Zhao J, Yan Y, Cui Z, et al. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. Hum Immunol. 2009;70:425\u20139.","journal-title":"Hum Immunol"},{"key":"750_CR12","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/clinchem\/33.10.1707","volume":"33","author":"RG Hamilton","year":"1987","unstructured":"Hamilton RG. Human IgG subclass measurements in the clinical laboratory. Clin Chem. 1987;33:1707\u201325.","journal-title":"Clin Chem"},{"key":"750_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.kint.2016.09.048","volume":"91","author":"DC Cattran","year":"2017","unstructured":"Cattran DC, Brenchley PE. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int. 2017;91:566\u201374.","journal-title":"Kidney Int"},{"key":"750_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1523-1755.2005.00498.x","volume":"68","author":"J Robertson","year":"2005","unstructured":"Robertson J, Wu J, Arends J, et al. Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis. Kidney Int. 2005;68:1061\u201370.","journal-title":"Kidney Int"},{"key":"750_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1046\/j.1365-2249.1997.4091307.x","volume":"109","author":"XR Huang","year":"1997","unstructured":"Huang XR, Tipping PG, Apostolopoulos J, et al. Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol. 1997;109:134\u201342.","journal-title":"Clin Exp Immunol"},{"key":"750_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1046\/j.1365-2249.2002.01859.x","volume":"128","author":"AR Kitching","year":"2002","unstructured":"Kitching AR, Huang XR, Ruth AJ, et al. Effects of CTLA4-Fc on glomerular injury in humorally-mediated glomerulonephritis in BALB\/c mice. Clin Exp Immunol. 2002;128:429\u201335.","journal-title":"Clin Exp Immunol"},{"key":"750_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1172\/JCI6710","volume":"105","author":"J Reynolds","year":"2000","unstructured":"Reynolds J, Tam FWK, Chandraker A, et al. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest. 2000;105:643\u201351.","journal-title":"J Clin Invest"},{"key":"750_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1046\/j.1523-1755.2003.00259.x","volume":"64","author":"AD Salama","year":"2003","unstructured":"Salama AD, Chaudhry AN, Holthaus KA, et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture\u2019s (anti-GBM) disease. Kidney Int. 2003;64:1685\u201394.","journal-title":"Kidney Int"},{"key":"750_CR19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ki.2013.364","volume":"85","author":"XY Jia","year":"2014","unstructured":"Jia XY, Hu SY, Chen JL, et al. The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int. 2014;85:945\u201352.","journal-title":"Kidney Int"},{"key":"750_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.ajkd.2020.11.023","volume":"78","author":"SB Ahmad","year":"2021","unstructured":"Ahmad SB, Santoriello D, Canetta P, et al. Concurrent anti-glomerular basement membrane antibody disease and membranous nephropathy: a case series. Am J Kidney Dis. 2021;78:219-225.e1.","journal-title":"Am J Kidney Dis"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00750-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T07:10:36Z","timestamp":1682925036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00750-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00750-x","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflicts of interest exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}